Promega Corporation

pAdVAntage™ Vector

Co-transfection of mammalian cells with the pAdVAntage™ Vector enhances transient protein expression in a variety of cell types by increasing translation initiation.

Transfection of mammalian cells with an expression vector often results in suboptimal expression of the protein of interest. Double-stranded RNA (dsRNA) generated during transfection is thought to activate the dsRNA-activated inhibitor (DAI), one of several enzymes involved in the host cell's antiviral defense system. DAI phosphorylates the translation initiation factor eIF-2, halting translation and therefore protein production.

However, DA...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega GmbH only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

pAdVAntage™ Vector

Close Window

pAdVAntage™ Vector

 Components

  • pAdVAntage™ Vector

    E171A1 x 20μg
20μg
- E1711 zł 598,00 Add to cart


You Also May Be Interested In

GenBank®/EMBL Accession Number

pAdVAntage™ Vector Accession Number U47294; pAdVAntage™ Vector sequence text file.

Storage Conditions

Store at –20°C.

For product intended use please see Patents & Disclaimers tab.

pAdVAntage Vector.Figure 1. pAdVAntage™ Vector.

Use Restrictions

E1711 For Research Use Only. Not for Use in Diagnostic Procedures.

Prefer a different language?

Your country is set to Poland. Your language is set to polski. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.